Rocket Pharmaceuticals, Inc.
RCKT
$3.39
-$0.15-4.24%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -12.04% | 12.27% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 5.11% | 2.70% | |||
| Operating Income | -5.11% | -2.70% | |||
| Income Before Tax | -12.37% | -1.67% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -12.37% | -1.67% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -12.37% | -1.67% | |||
| EBIT | -5.11% | -2.70% | |||
| EBITDA | -6.03% | -1.77% | |||
| EPS Basic | -11.43% | 9.93% | |||
| Normalized Basic EPS | -5.63% | 8.57% | |||
| EPS Diluted | -11.43% | 9.93% | |||
| Normalized Diluted EPS | -5.63% | 8.57% | |||
| Average Basic Shares Outstanding | 0.84% | 12.88% | |||
| Average Diluted Shares Outstanding | 0.84% | 12.88% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||